These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9550823)

  • 1. [Immunology in clinical practice. VII. Psoriasis].
    Bos JD; de Rie MA
    Ned Tijdschr Geneeskd; 1997 Nov; 141(48):2334-8. PubMed ID: 9550823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.
    Kormeili T; Lowe NJ; Yamauchi PS
    Br J Dermatol; 2004 Jul; 151(1):3-15. PubMed ID: 15270867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in the treatment of psoriasis.
    Rogers S
    Ir Med J; 1997; 90(5):178-9. PubMed ID: 9345825
    [No Abstract]   [Full Text] [Related]  

  • 4. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psoriasis: pathogenesis and treatment].
    Heenen M
    Rev Med Brux; 2003 Jun; 24(3):139-47. PubMed ID: 12891880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the T cell in psoriasis and the action of cyclosporin in this disease.
    Fry L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():133-4; discussion 134-5. PubMed ID: 2609854
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis--recent advances in understanding its pathogenesis and treatment.
    Krueger G; Ellis CN
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S94-100. PubMed ID: 15968269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2006 Aug; 47(3):151-9. PubMed ID: 16866993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating psoriasis as a T-cell mediated disease.
    Leonardi C
    Manag Care; 2004 Apr; 13(4 Suppl Treating Psoriasis):1, 3-8. PubMed ID: 15282980
    [No Abstract]   [Full Text] [Related]  

  • 10. From laboratory to clinic: rationale for biologic therapy.
    Mehlis S; Gordon KB
    Dermatol Clin; 2004 Oct; 22(4):371-7, vii-viii. PubMed ID: 15450333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis].
    Ferran M; Giménez-Arnau AM; Bellosillo B; Pujol RM; Santamaría-Babi LF
    Actas Dermosifiliogr; 2008 Nov; 99(9):701-7. PubMed ID: 19087808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model.
    Boehncke WH; Ochsendorf FR; Noll S; Urban M; Popp A; Waldherr D; Haunschild J; Litzenburger T
    Br J Dermatol; 2005 Oct; 153(4):758-66. PubMed ID: 16181457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
    Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
    Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How to understand psoriasis?].
    Bérard F; Guillot I; Saad N; Nicolas JF
    Rev Prat; 2004 Jan; 54(1):28-34. PubMed ID: 15049596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathogenesis and immunotherapy of psoriasis.
    Griffiths TW; Griffiths CE; Voorhees JJ
    Dermatol Clin; 1995 Oct; 13(4):739-49. PubMed ID: 8785879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study.
    Smith CH; Jackson K; Bashir SJ; Perez A; Chew AL; Powell AM; Wain M; Barker JN
    Br J Dermatol; 2006 Jul; 155(1):160-9. PubMed ID: 16792769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in systemic immunomodulatory therapy for psoriasis.
    Berger EM; Gottlieb AB
    Curr Opin Pharmacol; 2007 Aug; 7(4):434-44. PubMed ID: 17627886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacological approaches in the treatment of psoriasis.
    Schleyer V; Landthaler M; Szeimies RM
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):1-20. PubMed ID: 15649186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of psoriasis.
    Boehncke WH; Schön MP
    Clin Dermatol; 2007; 25(6):596-605. PubMed ID: 18021898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine on immunologic mechanisms in psoriasis.
    Cooper KD; Voorhees JJ; Fisher GJ; Chan LS; Gupta AK; Baadsgaard O
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1318-26; discussion 1326-8. PubMed ID: 2277141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.